Korea Pharmaceutical Manufacturers Association   Report issue

For profit Phase 2
Founded: Seoul Korea, Republic of (1945)
Status: No NME R&D (1945)

Organization Overview

First Clinical Trial
2013
NCT01979926
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

broussonetia spp (1 trial)

lonicera japonica (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Disease (Phase 2)

Bronchitis (Phase 2)

Bronchitis, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2